Riskpilot← Back to searchSign inGet full accessPHYTORECEPTORS ApS
APSActiveCVR 35820620Andkærvej 17AManufacture of pharmaceutical preparations · NACE 2120Est. 20141 employees
Revenue 2025
DKK 3,1M
-3% vs 2024
EBITDA margin
71.4%
-5% vs 2024
Equity ratio
12.7%
Financial strength
Net profit 2025
DKK 1,6M
-6% vs 2024
| Revenue | DKK 3,1M | -3% |
| EBITDA | DKK 2,2M | -5% |
| Net profit | DKK 1,6M | -6% |
| Total assets | DKK 29M | +30% |
| Equity | DKK 3,7M | +5% |
| Employees | 1 | — |
Legal name
PHYTORECEPTORS ApS
CVR number
35820620
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
1. april 2014
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør sammen med formanden for bestyrelsen eller et bestyrelsesmedlem sammen med formanden for bestyrelsen.
Company purpose
Selskabets formål er at udvikle og omsætte produkter til human helse samt udøve anden hermed forbunden virksomhed.
Address
Andkærvej 17A
Email
jdam@phytoreceptors.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -50 | -4 | 364 | 5.496 | 9.538 | 5.257 | 3.920 | 3.628 | 4.227 | 3.158 | 3.219 | 3.119 |
| Staff expenses | -0 | -0 | -0 | -1.177 | -3.000 | -441 | -953 | -884 | -906 | -891 | -886 | -892 |
| EBITDA | -50 | -4 | 364 | 4.320 | 6.538 | 4.816 | 2.946 | 2.743 | 3.321 | 2.267 | 2.333 | 2.227 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -13 | -27 | -111 | -54 | -31 | -18 | -15 |
| EBIT | -50 | -4 | 364 | 4.320 | 6.538 | 4.802 | 2.919 | 2.632 | 3.266 | 2.236 | 2.315 | 2.212 |
| Net financials | -0 | -2 | -7 | 2 | 1 | 39 | -35 | -72 | -60 | 96 | -111 | -137 |
| Profit before tax | -50 | -6 | 357 | 4.321 | 6.539 | 4.842 | 2.884 | 2.561 | 3.207 | 2.332 | 2.204 | 2.075 |
| Tax | -11 | -1 | 80 | 966 | 1.440 | 1.073 | 649 | 566 | 707 | 515 | 494 | 474 |
| Net profit | -40 | -6 | 277 | 3.356 | 5.099 | 3.769 | 2.235 | 1.994 | 2.499 | 1.817 | 1.710 | 1.601 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 117 | 112 | 1.933 | 8.720 | 14.458 | 17.812 | 13.808 | 10.899 | 23.431 | 22.398 | 22.358 | 29.027 |
| Equity | 10 | 4 | 282 | 3.637 | 5.599 | 4.269 | 3.235 | 2.994 | 3.499 | 3.317 | 3.510 | 3.691 |
| Long-term debt | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 | 8 | 1.652 | 5.083 | 8.859 | 13.532 | 10.551 | 7.892 | 19.922 | 19.048 | 18.823 | 25.313 |
| Total debt | 106 | 108 | 1.652 | 5.083 | 8.859 | 13.532 | 10.551 | 7.892 | 19.922 | 19.048 | 18.823 | 25.313 |
EBITDA margin
71.4%
This company
15.8%
Market median
+352% vs market
20142025
Equity ratio
12.7%
This company
38.2%
Market median
-67% vs market
20142025
Return on equity
43.4%
This company
18.4%
Market median
+136% vs market
20142025
Net profit margin
51.3%
This company
8.1%
Market median
+533% vs market
20142025
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20142025
Debt / equity
6.86×
This company
0.62×
Market median
-1006% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-04-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JF Management | Management | 2014 | — | — |
HL Management | Management | 2017 | — | — |
LH Management | Management | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — | |
| Board of Directors | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DAM-ANDERSEN ApS | Company | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DAM-ANDERSEN ApS
PHYTORECEPTORS ApS Board members of PHYTORECEPTORS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Fredelund | Management | 0 companies |
| Henrik Lund Uth | Management | 0 companies |
| Lars Hagh Petersen | Management | 0 companies |
| Jørgen Dam | Chairman | 0 companies |
| Anne Bornø Andersen | Board of Directors | 0 companies |